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Abstract
Background: Surface plasmon resonance is a label-free biophysical technique that is widely used in investigating
biomolecular interactions, including protein-protein, protein-DNA, and protein-small molecule binding. Surface
plasmon resonance is a very powerful tool in different stages of small molecule drug development and antibody
characterization. Both academic institutions and pharmaceutical industry extensively utilize this method for
screening and validation studies involving direct molecular interactions. In most applications of the surface plasmon
resonance technology, one of the studied molecules is immobilized on a microchip, while the second molecule is
delivered through a microfluidic system over the immobilized molecules. Changes in total mass on the chip surface
is recorded in real time as an indicator of the molecular interactions.
Main body: Quality and accuracy of the surface plasmon resonance data depend on experimental variables,
including buffer composition, type of sensor chip, coupling chemistry of molecules on the sensor surface, and
surface regeneration conditions. These technical details are generally included in materials and methods sections of
published manuscripts and are not easily accessible using the common internet browser search engines or
PubMed. Herein, we introduce a surface plasmon resonance database, www.sprdatabase.info that contains technical
details extracted from 5140 publications with surface plasmon resonance data. We also provide an analysis of
experimental conditions preferred by different laboratories. These experimental variables can be searched within
the database and help future users of this technology to design better experiments.
Conclusion: Amine coupling and CM5 chips were the most common methods used for immobilizing proteins in
surface plasmon resonance experiments. However, number of different chips, capture methods and buffer
conditions were used by multiple investigators. We predict that the database will significantly help the scientific
community using this technology and hope that users will provide feedback to improve and expand the database
indefinitely. Publicly available information in the database can save a great amount of time and resources by
assisting initial optimization and troubleshooting of surface plasmon resonance experiments.
Keywords: Surface plasmon resonance (SPR), Sensor chip, Analyte-ligand interactions, And equilibrium dissociation
constant
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Background
Surface plasmon resonance (SPR) is one of the most
commonly used label-free biophysical techniques that
can provide real-time information on interaction of two
molecules [1–3]. There have been many successful commercial applications of this technology. Several applications using sensorchips made of thin continuous gold
layer includes but not limited to Biacore (Cytiva), BI
(Biosensing instruments), ProteOn (Bio-Rad), Carterra
LSA (Carterra), Reichert 4/2SPR (Xantec Bioanalytics),
Sierra SPR-32/24 Pro (Bruker), MP-SPR Navi (BioNavis),
Pioneer (ForteBio), P4SPR (Affinite Instruments). Besides, conventional SPR on the continuous metal surface,
there are other biosensing applications based on nanoparticles as sensors that include but not limited to
OpenSPR (Nicoya) and SoPRano (BMG LABTECH)
using localized surface plasmon resonance (LSPR) technology [4] as well as INB-D200 (INSTANT NanoBiosensors) using fiber optic particle plasmon resonance
(FOPPR) [5] utilizing SPR effects. The SPR technique is
very useful in SM binding [6, 7], hit validation [7], and
lead identification [8] in drug discovery via the detection
of direct molecular interactions [9]. One of the two
interacting partners is immobilized on the metal chip
surface (ligand) whereas the other binding partner in solution (analyte) is flown over the ligand-immobilized
surface [10]. On the other side of the metal chip, an incident light is directed to the ligand free surface at an
angle to achieve total internal reflection and the reflection angle is recorded in real-time. Upon binding of the
analyte to the ligand, due to the change in mass, the refractive index changes [11, 12]. This change in the refractive index corresponds to the SPR signal, which can
be calculated as a change in total mass on the chip surface and the data is presented as SPR sensorgrams [13].
SPR data can be fitted to physical equations to determine the kinetics rate constants, association rate constant (ka or kon), dissociation rate constant (kd or koff),
and equilibrium dissociation constant (KD) of different
types of biomolecular interactions, including monophasic and biphasic interactions [14–18].
The quality of the SPR data depends on the several external factors such as buffer compositions [19], types of
the sensor chip with different matrix on the gold surface
[20–22], and coupling techniques of ligands on the sensor surface [23, 24]. For slow dissociating analyte-ligand
interactions, the chip surface has to be regenerated with
proper regeneration solution without affecting the ligand
activity [25]. Therefore, several factors have to be considered and optimized to generate good quality SPR
data. Experiments initially may require a big investment
of time and resource to find the optimum conditions for
a specific pair of ligand and analyte that are being studied. Many labs will go through a trial and error process
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to troubleshoot these steps based on their experience
with similar molecules. New users of this technology
and experienced users dealing with a completely new
class of molecules spend valuable time and research
funding to determine the best approach.
Here, we introduce a SPR database (SPRD) with
searchable experimental details from 5140 publications.
These experimental factors can be searched within the
database and are very helpful for users to design new experiments, which are related to particular biomolecules
already used in the previous experiments. Although we
focused to gather information from publications with
conventional SPR systems using sensorchips made of
continuous thin metal layer, the information included in
our database is also useful for researchers using other instruments based on derivative techniques such as LSPR
and FOPPR to investigate biomolecular interactions. The
searchable experimental factors include, ligand, analyte,
sensorchip, running buffer, and regeneration solution.
The SPRD will save significant amount of time and resources that would have been invested at the beginning
of SPR experiments to figure out the optimal experimental conditions and potential troubleshooting. The database is designed to be corrected, updated, and expanded
by input from its users.

Construction and content
Literature included in SPRD

Experimental details in the SPRD were assembled as
5500 entries in the database from a library of 5140
manuscripts containing SPR studies. The library was
compiled through using key words in different search
engines. We used “Biacore” keyword in PubMed
(https://pubmed.ncbi.nlm.nih.gov/). We also included
manuscripts that were evaluated in five review articles
on SPR [26–30]. These searches resulted in ~ 8200 publications. Review articles and papers with theoretical data
without experimental validation were excluded. Manuscripts that did not describe SPR experiments with
enough detail were also excluded. Only the manuscripts
written in English were included. We were limited with
availability of full text manuscript based on subscription
list of Georgetown University library. Therefore, the final
number of manuscripts we could include in the library
was 5140 in November 2020.
Data entry

Each manuscript in the library was read by one of the
authors and technical details about the SPR experiment
were entered and managed in Research Electronic Data
Capture (REDCap) electronic data capture tool hosted at
Georgetown University [31, 32]. If available, the following details were recorded for each manuscript; name of
the ligand(s), name of the analyte (s), ligand’s protein
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tag, analyte’s protein tag, ligand class (protein, DNA,
RNA, SM etc.), analyte class (protein, DNA, RNA, SM
etc.), type of sensorchip, name of SPR instrument, ligand
immobilization or capture method, immobilization or
capture buffer, immobilization or capture running buffer, ligand immobilization or capture level, kinetics running buffer, kinetics regeneration solution, ka, kd, and
KD. If ligands were captured using intermediate
molecules immobilized on the sensor surface first, we
also captured the name, immobilization method,
immobilization buffer, immobilization running buffer,
and immobilization level of the intermediate molecule.
For each set of data entry, we provided the PubMed
unique identifier number (PMID) and a hyperlink to it.
If there were more than two entirely different interaction
types found in the same publication, we captured each
information as an independent entry. Therefore, the
SPRD has 5500 entries from the library of 5140 different
publications. If the publication reported different mutants of the same ligand or analyte, we only captured information related to the wild-type form.
Utility and discussion

SPR experiments can be designed to get binary results to
evaluate if a ligand directly binds to an analyte or not.
They can also be designed to screen analyte libraries
composed of SMs, peptides or oligos. A significant number of experiments seek to identify the kinetics parameters (ka, kd, KD) of the specific analyte-ligand interaction.
Both the binary results and the kinetics parameters determined by any SPR experiment may significantly vary
depending on buffer conditions, chip types, and ligand
immobilization procedures. For example, the KD values
of interactions between wilt-type Eap45 GLUE domain
and ubiquitin were found to be ~ 411 μM and ~ 261 μM
in phosphate and tris buffers, respectively [19]. Likewise,
the KD value for Factor H (fH) binding to C3b was
found to be about three times higher using a CM5 chip
(~ 2.2 μM) when compared to using a C1 chip (~
0.7 μM), using the same ligand coupling chemistry and
buffer condition [22]. Unlike CM5, the C1 chip does not
have a dextran matrix coated on the sensor surface [33].
It is to be noted that the lower ligand immobilization
level used for the C1 chip (140 RU) as compared to the
CM5 chip (384 RU) might also be the contributing factors for the change in the KD values in this study [22].
Moreover, when PD-1was immobilized on a CM5 chip
by amine coupling [23] or biotin-tagged PD-1 was captured on a streptavidin (SA) coated chip [24], calculated
KD value for binding to PD-L1 changed approximately
28 fold (~ 0.9 μM [23] vs. ~ 25 μM [24]). In this example,
difference in the sources of interacting partners (PD-1
and PD-L1) may have contributed to the difference in
KD values too. There is a variation in reported KD values
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for antigen-antibody interactions when immobilization
method of antibody (ligand) using standard amine coupling chemistry changed to the capture of the antibody
(ligand) using a secondary antibody immobilized on the
same chip surface [34]. Therefore, the results from the
same ligand and analyte interaction can be completely
different based on simple experimental conditions. A
user who wants to start a new SPR experiment for an
analyte-ligand pair faces a number of choices for the
chip, capture method, and buffer conditions. Testing all
possible combinations of these factors is not practical
and not feasible in some cases. Therefore, we decided to
generate the SPRD to assist future users of SPR technology to take full advantage of the collective knowledge in
SPR literature.
When it was clearly stated in the original publication,
we recorded the following details related to SPR experiments in the SPRD:
Reference

We present the title of the publication, PMID and the
hyperlink to PubMed for each data entry. SPRD users
can reach to the original publication to see the entire details of the SPR experiments and relevant information
on the source of key materials.
Ligand name

The name of the ligand was entered as it appeared in
the original paper. If the ligand is a protein, its alternative names can be searched in GeneCards hyperlink
(www.genecards.org) that is provided in the SPRD results page. If the ligand name was not provided in the
original manuscript, the entry was listed under
“Undefined”.
Other ligands used

If a publication had multiple ligands that were immobilized in the same experiments using a similar coupling
chemistry, we captured their names in the same record.
However, the SPRD does not have detailed kinetics information for each ligand. We recommend users to follow the reference for details.
Analyte name

This corresponds to the name of the analyte that was
flowed over the ligand-immobilized surface. The database entry has subsequent information related to the
binding of this single analyte to the ligand for each entry.
If the analyte is a protein, its alternative names can be
searched in GeneCards hyperlink (www.genecards.org)
that is provided in the SPRD. If the analyte name was
not provided in the original manuscript, the entry was
listed under “Undefined”.
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Some ligands had tags for easier purification or
immobilization. Commonly used protein purification
tags are 6xHis, GST, FLAG and Mcy. When they
were used, their names were included under this
category.

(anti-His capture), the capture of GST-tagged ligands on
an anti-GST antibody immobilized surface (anti-GST
capture), the capture of biotin-tagged ligands on a streptavidin- or neutravidin-coated surface (biotin-capture),
immobilization using thiol coupling chemistry (thiol
coupling), immobilization using maleimide chemistry
(maleimide coupling), and capture of ligands on ligand
specific antibody immobilized surface (antibody capture).
If the immobilization or capture method mentioned in
the publication was not any of the above-mentioned
methods, we recorded that information as “other”. If the
capture method was not explained in the original manuscript, the entry was listed under “Undefined”.

Analyte tag

Immobilization or capture buffer

They were captured similar to ligand tags.

We recorded the composition and pH information of
the buffer in which the ligand was diluted for
immobilization step.

Other analytes used

If a publication presented multiple analytes that were
also flowed over the same ligand-immobilized surface,
we captured their names. The SPRD does not have detailed kinetics information for each analyte. We refer
users to the original manuscript for details.
Ligand tag

Ligand class

Each ligand was assigned to class of molecules, which included protein, DNA, RNA, SM, peptide, and antibody.
If the class of the ligand did not fit any of these, it was
entered as “other”. If the ligand class was not provided
in the original manuscript, the entry was listed under
“Undefined”.
Analyte class

Analyte classes were captured similar to ligands. If the
analyte class was not provided in the original manuscript, the entry was listed under “Undefined”.
Sensorchip used

We recorded the type of sensorchip used in the SPR experiments as mentioned in each publication. The types
of sensorchips included C1, CM3, CM4, CM5, CM7,
HPA, L1, NTA, PEG, and SA chip. Since majority of the
experiments were using Biacore instruments, the chip
categories were matched to its manufacturer’s nomenclature. If the type of the sensorchip was not any of the
types mentioned above, we entered the chip type(s) as
“other”. If the chip information was not provided in the
original manuscript, the entry was listed under
“Undefined”.
Instrument used

We recorded the name of the commercial biosensor instrument that was used to run the SPR experiment.
Immobilization or capture method

If the immobilization or capture method was mentioned
in the publication, we recorded that information. These
methods included, immobilization using the amine
coupling chemistry (amine coupling), the capture of Histagged ligand on a nickel chelated NTA surface (Ni2+NTA capture) or anti-His antibody immobilized surface

Immobilization or capture running buffer

We recorded the composition and pH information of
the buffer, which runs in the background during
immobilization or capture of the ligand. In many experiments, this buffer was different from the immobilization
or capture buffer in which the ligand was diluted
directly.
Immobilization or capture level

We recorded the response amplitude obtained when ligands were immobilized or captured on the sensor surface. The unit of this amplitude varies depending on the
SPR-based biosensor instrument. In Biacore instruments,
which were the most common tool, it was response unit
(RU).
Intermediate molecule

In some experiments, ligands were captured on the surface on which another molecule was already immobilized. For example, in anti-His capture of His-tagged
ligand, the anti-His antibody was first immobilized on
the chip surface and then the His-tagged ligand was flowed through. Here the anti-His antibody was considered
as the intermediate molecule. If this molecule was required in a particular experiment and based on the availability of the information in the publication, we recorded
class, immobilization method, immobilization buffer and
pH, immobilization running buffer and pH, and
immobilization level for the intermediate molecule as we
have done that for ligands.
Kinetics running buffer

This is the buffer that was used to dilute analyte before
it was injected into SPR instruments and the same buffer
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that runs in the background. We recorded the composition and pH of the kinetics running buffer.
Kinetics regeneration solution

Very strong analyte-ligand interactions have small kd
values, which indicates a very slow dissociation of analyte form the ligand. Since the sensor surface has to be
regenerated for the next cycle of the analyte injection, a
regeneration solution is used to dissociate the analyteligand complex without damaging the activity of the
ligand on the chip surface [25]. We recorded the composition and pH of the regeneration solution.
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 Interactive dashboards
 Search based on the recorded features (ligand,

analyte, chip used, immobilization method used or
reference)
 Access publications in PubMed – search based on
regular expression, matching characters or
PubMed’s Identifier (PMID)
 Submit and report errors (forms)
 Submit new entries – for the team to assess and
validate before making them public.
Figure 1 illustrates the workflow and different components developed and implemented for the project. The
portal can be accessed via http://www.sprdatabase.info.

ka, kd, and KD

We recorded the association rate constant (ka or kon),
dissociate rate constant (kd or koff), and the equilibrium
dissociation constant (KD) of the interactions between
the ligand and analyte.
SPRD web portal

We designed and implemented a publicly accessible and
searchable web portal available to query current resources and information in the collected and curated
data repository based on different experimental factors
and data elements captured in the database. The portal
features additional capabilities that include:

Fig. 1 SPRD information workflow

Data collection

To collect and manage SPRD data entries, we designed
and implemented data collection instruments hosted
and managed in the Georgetown REDCap based system,
a secure, web-based application designed exclusively for
building and managing online surveys, study data management and monitoring for research studies. REDCap
was developed by Vanderbilt University and the REDCap
Consortium, a collection of 4683 institutions from 139
countries currently utilizing the software and contributing to its continuing enhancement and maintenance
[35]. REDCap is an easy-to-use, and secure method of
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flexible yet robust data collection. We manually entered
and curated data from 5140 manuscripts found in
PubMed and implemented a capability for the public to
submit new entries that will be validated by the team before publication in the portal.
We developed Extract, Transform, and Load procedures to copy data from REDCap entries and PubMed
sources into a cloud based destination database, which
represents the data in a structured searchable format
hosted in the Google Cloud Platform (GCP). We leveraged PyMed [36], a Python library that provides access
to PubMed through the PubMed API using Python, to
retrieve data and links from PubMed.
All SPRD data are hosted and managed in the
Georgetown University Cloud-based Virtual Research
Environment (VRE), leveraging the Google Cloud
Platform (GCP) for provisioning computing resources,
securely storing and sharing data. The VRE was designed
and developed to overcome barriers met by the research
community while complying with institutions’ policies
and current state and federal policies and regulations. It
is a multi-mission platform that can facilitate the advancement of science, education, and services and will
enable the SPRD and investigators to participate in and
share data, information and knowledge with the community and research networks. Users can visit www.
sprdatabase.info to access the database for the information discussed above. The webpage, especially different
tabs within the blue stripe at the left side of the webpage, guides the users to access information included in
the database. Clicking “more here” in the search results
that is obtained by accessing “Search the database” tab
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provide access to additional details about the particular
entry. At the time of this manuscript submission, we recorded information from 5500 REDCap database entries.
We will be updating the database by adding new publications in the future and we encourage users to submit
their data as well.
The 5500 entries we collected from 5140 publications so
far had a wide range of experimental conditions, which
were most likely optimized for the specific analyte-ligand
conditions. CM5 was the mostly used chip (~ 60%) as
compared to other types of sensorchips (Fig. 2a). Amine
coupling chemistry was the most preferred method (~
48%) of ligand immobilization (Fig. 2b). This observation
indicates that CM5 chip and amine coupling chemistry
were the most commonly used sensorchip type and ligand
coupling chemistry, respectively. We also observed that
“Biacore instruments” were the most frequently used SPR
instruments (~ 88%) and the “Biacore 3000” was the most
commonly used instrument (~ 40%). Moreover, “protein”
was the leading class of ligand (~ 58%) and analyte (~
56%) as compared to other ligand and analyte classes.
Future work

As we launch SPRD with an initial repository of 5500
complete and curated data entries, we anticipate it to
grow into a much larger, freely available and trusted
knowledge base with up to date information. The envisioned system will require the development of a framework that enables custom design and can scale to
accommodate additional workflows, new potential data
sources and collaboration options a custom developed
web application coupled with a database system can

Fig. 2 Distribution of most commonly used sensorchips (a) and ligand coupling chemistries (b) are shown in bar graphs. If the chip type or
coupling chemistry was not stated in the original manuscript, it was assigned to “Undefined” group. Numbers next to bars represent the
sample size
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enable new advanced features to design and implement
custom developed forms, visualization and reporting
capabilities.
Roadmap and future development will consider the
automation of data ingestion from different sources and
data export to SPRD data repository. We can leverage
the available REDCap application programming interface
(API), a RESTful web service for storing and retrieving
data to and from REDCap. We will survey users, data
custodians and the community for feedback and desired
new features.

Conclusions
In summary, the SPRD guides users to search for various
analyte-ligand pairs or capture methods in the database.
The search results will help users to choose different ligand immobilization/capture strategies, optimum buffer
for immobilization, and surface regeneration conditions
for a particular ligand. Therefore, the SPRD can be very
helpful to efficiently design and execute SPR experiments both for experienced and novice SPR users. We
would like to state that our database doesn’t cover entire
SPR-based publications so far, however, we will continue
to add more information in the future. Our database also
offers users an opportunity to correct the mistakes in
the SPRD and to enter information from their own or
other’s publications that are not included in the database. We would like to request users to notify us if they
find errors in the recorded information so that we can
correct it in the database. These functionalities can be
accessed at the SPRD webpage by clicking “Report a
mistake in the database” tab to report mistakes and
“Add a new entry to the database” to enter information
from their own or other’s publication that are not included in the database.
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